Recent issues in contrast-induced nephropathy

International Journal of Urology

Volumn 18, Issue 10, 2011, Pages 686-690

  Kitajima, Kazuhiro ^a   Maeda, Tetsuo ^a   Watanabe, Sanae ^a   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Computed tomography; Contrast medium; Contrast induced nephropathy

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; CREATININE; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHLORIDE;

CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFICACY; DRUG WITHDRAWAL; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEMODIALYSIS; HEMOFILTRATION; HOSPITALIZATION; HUMAN; HYDRATION; KIDNEY FAILURE; KIDNEY FUNCTION; NEPHROTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

CONTRAST MEDIA; HUMANS; KIDNEY DISEASES;

EID: 80053122151     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2011.02830.x     Document Type: Review

References (41)

1. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 2002; 39: 930-6.
2. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort snalysis. JAMA 1996; 275: 1489-94.
3. Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am. J. Roentgenol. 2003; 181: 1463-71.
4. Morcos SK, Thomsen HS. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom. Imaging 2003; 28: 187-90.
5. Thomsen HS, Morcos SK. ESUR guidelines on contrast media. Abdom. Imaging 2006; 31: 131-40.
6. Thomsen HS, Morcos SK. In which patients should serum creatinine be measured before iodinated contrast medium adminidtration? Eur. Radiol. 2005; 15: 749-54.
7. Halvorsen RA. Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging. Radiology 2008; 249: 9-15.
8. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2003; 39 (Suppl 1): S1-266.
9. Diskin CJ. Creatinine and glomerular filtation rate: evolution of an accommodation. Ann. Clin. Biochem. 2007; 44: 16-19.
10. Poggio ED, Nef PC, Wang X etal. Performance of the Cockroft-Gault and Modification of Diet in Renal Disease equations in estimating GFR in ill hospitalized patients. Am. J. Kidney Dis. 2005; 46: 242-52.
11. Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc. Intervent. Radiol. 2005; 28 (Suppl 2): S3-11.
12. Barrett BJ, Katzberg RW, Thomsen HS etal. Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography. A double blind comparison of iodixanol and iopamidol. Invest. Radiol. 2006; 41: 815-21.
13. Thomsen HS, Morcos SK, Earley CM etal. The ACTIVE trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest. Radiol. 2008; 43: 170-8.
14. Nguyen SA, Suranyi P, Ravenel JG etal. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 2008; 248: 97-113.
15. Weisbord SD, Mor MK, Resnick AL etal. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin. J. Am. Soc. Nephrol. 2008; 3: 1274-81.
16. Kuhn MJ, Chen N, Sahani DV etal. The PRDICT study: a randomized double-blind comparison of contrast-induced nepropathy after low- or iso-osmolar contrast agent exposure. AJR Am. J. Roentgenol. 2008; 181: 151-7.
17. Thomsen HS, Morcos SK. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT: a pooled analysis of two randomized trials. Eur. Radiol. 2009; 19: 891-7.
18. Lencioni R, Fattori R, Morana G, Stacul F. Contrast-induced nephropathy in patients undergoing computed tomography (CONNET): a clinical problem in daily practice ? A multicenter observational study. Acta Radiol. 2010; 51: 741-50.
19. Katzberg RW, Barrett BJ. Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology 2007; 243: 622-8.
20. Gruberg L, Mintz GS, Mehran R etal. The prognostic implications of further renal function deterioration within 48h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J. Am. Coll. Cardiol. 2000; 36: 1542-8.
21. Mitchell AM, Jones AE, Tumlin JA, Kline JA. Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting. Clin. J. Am. Soc. Nephrol. 2010; 5: 4-9.
22. Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am. J. Roentgenol. 2004; 183: 1673-89.
23. Stacul F, Adam A, Becker C etal. Strategies to reduce the risk of contrast-induced nephropathy. Am. J. Cardiol. 2006; 98 (Suppl 1): 59-77.
24. Reddan D, Fishman EK. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists. Eur. J. Radiol. 2008; 66: 235-45.
25. Parfrey PS, Griffiths SM, Barrett BJ etal. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N. Engl. J. Med. 1989; 320: 143-9.
26. Snyder S, Pendergraph B. Detection and evaluation of chronic kidney disease. Am. Fam. Physician 2005; 72: 1723-32.
27. Stigant C, Stevens L, Levin A. Nephrology: 4. Strategies for the care of adults with chronic kidney disease. CMAJ 2003; 168: 1553-60.
28. Mueller C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int. Suppl. 2006; 100: S16-19.
29. Thomsen HS. Current evidence on prevention and management of contrast-induced nephropathy. Eur. Radiol. 2007; 17 (Suppl 6): F33-7.
30. Hogan SE, L'Allier P, Chetcuti S etal. Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. Am. Heart J. 2008; 156: 414-21.
31. Committee on Drugs and Contrast Media, American College of Radiology (ACR) Website. Mannual on Contrast Media, v. 6. [Cited 4 Jan 2009.] Available from URL.
32. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, manitol, and furosemide on acute decreases in renal function induced by radiocontrastagents. N. Engl. J. Med. 1994; 331: 1416-20.
33. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann. Intern. Med. 2008; 148: 284-94.
34. Rudnick MR, Goldfarb S, Wexler L etal. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995; 47: 254-61.
35. Ellis JH, Cohan RH, Sonnad SS, Cohan NS. Selective use of radiographic low-osmolality contrast media in the 1990s. Radiology 1996; 200: 297-311.
36. Reed M, Meier P, Tamhane UU, Welch KB, Moscussi M, Gurm HS. The relative renal safety of iodixanol compared with low-osmolar contrast media. JACC Cardiovasc. Interv. 2009; 2: 645-54.
37. Heinrich MC, Haberle L, Muller V, Bautz W, Uder M. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009; 250: 68-86.
38. Alamartine E, Phayphet M, Thibaudin D, Barral FG, Veyret C. Constrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations. Eur. J. Intern. Med. 2003; 14: 426-31.
39. Sterner G, Frennby B, Mansson S, Ohisson A, Prutz KG, Almen T. Assessing residual renal function and efficiency of hemodialysis: an application for urographic contrast media. Nephron 2000; 85: 324-33.
40. Morcos SK, Thomsen HS, Webb JAW, Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR). Dialysis and contrast media. Eur. Radiol. 2002; 12: 3026-30.
41. Marenzi G, Marana I, Lauri G etal. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N. Eng. J. Med. 2003; 349: 1333-40.